8 unchanged sentences
and AstraZeneca AB, dated as of October 20, 2014.
−Removed: FibroGen, Inc.
−Removed: 2024 Equity Incentive Plan .
−Removed: First Amended and Restated Evaluation Agreement by and between FibroGen, Inc.
−Removed: and Fortis Therapeutics, Inc., dated June 6, 2024.
−Removed: First Amended and Restated Option Agreement and Plan of Merger by and among FibroGen, Inc., Fortis Therapeutics, Inc.
−Removed: and Shareholder Representative Services LLC, as Sellers’ Representative, dated June 6, 2024.
−Removed: Form of Restricted Stock Unit Grant Notice and Award Agreement .
−Removed: Form of Stock Option Grant Notice and Option Agreement .
Certification of Chief Executive Officer, as required by Rule 13a-14(a) or Rule 15d-14(a).
10 unchanged sentences
FibroGen, Inc.
−Removed: August 6, 2024
+Added: November 12, 2024
/s/ Thane Wettig
1 unchanged sentence
(Principal Executive Officer)
−Removed: August 6, 2024
+Added: November 12, 2024
/s/ Juan Graham
2 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.